Additionally, analysis of data from the Religious Orders Study (ROS) and Rush Memory and Aging Project (MAP), referred to in combination as ROSMAP, patients with AD had higher MFGE8 vascular expression levels, which were associated with accelerated cognitive decline [75]. Here, MFGE8 is linked to Alzheimer disease.